Pharmaceuticals, Biotechnology and Life Sciences
SOBI and Bioverativ on Monday announced the results of a new post-hoc longitudinal analysis demonstrating that individualised dosing with extended…
People with either type 1 or type 2 diabetes treated with Tresiba had fewer episodes of low blood sugar (hypoglycaemia) compared…
We are very proud to be partnering with the ProcureCon Pharma 2018, the only event in Europe for senior pharma…
GlaxoSmithKline said on Wednesday that new data from a Phase III clinical study supports the safety and efficacy of Shingrix…
ADC Biotechnology (ADC Bio) – a specialist ADC contract services company with proprietary conjugation technology designed to overcome process and aggregation…
Plasticell, a developer of innovative stem cell technologies and cell therapies, today announced it will collaborate with Anthony Nolan, a…
Mylan and its partner, Aspen have announced the U.S. launch of Myleran (busulfan) Injection, 60 mg/10 mL (6 mg/mL) Single-dose…
Switching to Tresiba from another basal insulin benefits people with diabetes regardless of whether or not their blood sugar levels…
It was reported by the certain people with type 2 diabetes that once-daily Xultophy (insulin degludec/liraglutide) was a better option…
Probiodrug, a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer’s disease (AD), and the Dutch biotech company Crossbeta Biosciences have extended their strategic…